Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announces that it has completed the acquisition of Riverpoint Medical (“Riverpoint Medical” or “Riverpoint”) from Arlington Capital Partners. Riverpoint is a category leader in high-growth minimally invasive surgical consumables, including advanced surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgical applications. “Riverpoint Medical is a market-leading, high-growth surgical consumables business growing revenue and cash flow at twice Novanta’s rate,” said Matthijs Glastra, Novanta’s Chair & Chief Executive Officer.
Read the full article: Novanta Completes Acquisition of Riverpoint Medical //
Source: https://www.businesswire.com/news/home/20260727169263/en/Novanta-Completes-Acquisition-of-Riverpoint-Medical